Forte Biosciences

United States
Los Angeles, California, United States, 94103

Company profile

Forte Biosciences company profile

Forte Biosciences is a biotechnology company that focuses on dermatology. The company's lead product, FB-401, is a topically applied live biotherapeutic developed in collaboration with the National Institutes of Health and the National Institute of Allergy and Infectious Diseases for the treatment of inflammatory skin disease.

Business identity

Contact email
[email protected]
Phone number
(858) 625-1025
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2017-01-01, Year

Headquarters

Postal code
94103
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
5
Total equity funding
$173.8M
Last funding
Post IPO Equity / $75M / 2025-06-25
Last equity funding
Post IPO Equity / $75M
Investors
9
Founders
1
Articles
85
Exited on
2020-06-16

Founders and investors

Founders

Paul Wagner

Investors

Biotechnology Value FundFarallon Capital ManagementJanus Henderson InvestorsOrbiMedPerceptive Advisors